Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.550
+0.110 (2.48%)
At close: Nov 3, 2026, 4:00 PM EST
4.580
+0.030 (0.66%)
Pre-market: Nov 4, 2026, 4:05 AM EST
Prime Medicine Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| LifeSci Capital | LifeSci Capital | Buy Maintains $6 | Buy | Maintains | $6 | +31.87% | Oct 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $8 | Buy | Reiterates | $8 | +75.82% | Oct 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $11 | Buy | Reiterates | $11 | +141.76% | Sep 25, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $9 | Buy | Maintains | $9 | +97.80% | Sep 25, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Sep 25, 2026 |
| Chardan Capital | Chardan Capital | Buy Maintains $7 | Buy | Maintains | $7 | +53.85% | Sep 25, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Aug 10, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $5 | Buy | Maintains | $5 | +9.89% | Aug 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.